Rivaroxaban Stada 15 mg + 20 mg hard capsules

Rivaroxaban Stada is a pharmaceutical product manufactured by Stada Arzneimittel AG, a German company known for its generic and over-the-counter medications. The product is primarily produced in Germany, with potential manufacturing in other locations. Rivaroxaban is an antithrombotic agent used to prevent and treat blood clots, including deep vein thrombosis and pulmonary embolism. The product is available in various European countries, including Latvia, Lithuania, and Slovakia, where it is registered and marketed under the name Rivaroxaban Stada. The marketing authorization holder in these countries is Stada Arzneimittel AG, Germany. The product is available in different strengths, such as 15 mg and 20 mg, and is typically supplied in blister packs. The shelf life of the product is generally 36 months, and it is intended for oral use. The product is subject to medical prescription and is classified under the ATC code B01AF01, indicating its use as an antithrombotic agent.